Specialized Hospital For Active Treatment Of Childrens Diseases Professor Ivan Mitev

At the Specialized Hospital For Active Treatment Of Childrens Diseases Professor Ivan Mitev in Sofia, clinical research in pediatric gastroenterology focuses on inflammatory bowel disease and related immune-driven conditions. Studies are evaluating whether new therapies can better control symptoms, improve disease activity, and support safer long-term care for children and adolescents.

• Ulcerative colitis and Crohn’s disease in pediatric patients
• Vedolizumab research for treatment effectiveness and long-term safety
• Risankizumab and upadacitinib studies for active Crohn’s disease

These trials aim to expand treatment options for children with difficult-to-control intestinal inflammation and to improve everyday disease management.

Another major area of research at this hospital is functional constipation, a common pediatric digestive disorder. The studies are designed to test new approaches that may ease bowel symptoms, improve comfort, and provide more reliable care for very young children.

• Functional constipation in children from infancy through early childhood
• Linaclotide studies comparing symptom relief with placebo
• Research focused on safety, tolerability, and long-term benefit

These trials support better understanding of how to treat constipation when standard care is not enough.

Clinical trials in nutritional and metabolic disorders include pediatric obesity and conditions linked to excess body weight. The research is centered on evaluating new therapies that may help with weight management and related health risks in children and adolescents.

• Obesity and type 2 diabetes in young people
• Cagrilintide and CagriSema studies for weight management
• Trials aimed at improving long-term metabolic health

This work reflects growing attention to early treatment of metabolic disease in pediatric populations.

Research in blood-related diseases at the site includes treatment of anemia associated with chronic kidney disease. The main purpose is to assess whether new therapies can support healthier blood levels and improve care for children living with chronic illness.

• Anemia in children and adolescents with chronic kidney disease
• Roxadustat studies evaluating treatment benefit and safety
• Focus on better management of kidney-related complications

These trials help address a frequent and burdensome complication of pediatric kidney disease.

Kidney-focused trials at the Clinic of Chidren Gastroenterology also examine proteinuria and related complications in children with chronic kidney disease. The studies are intended to test whether new treatments can reduce protein loss in urine and support safer long-term kidney care.

• Chronic kidney disease with proteinuria
• Finerenone research for kidney protection and treatment effectiveness
• Evaluation of safety when used alongside standard kidney medicines

This area of research aims to improve outcomes for children with progressive kidney disease.

The site is also involved in pediatric growth research, including children with short stature related to small for gestational age, Turner syndrome, Noonan syndrome, or idiopathic short stature. These studies are evaluating whether growth-focused treatment options can better support height gain and overall development.

• Short stature in children with growth-related conditions
• Somapacitan compared with established growth treatment
• Research aimed at improving growth outcomes in pediatric endocrinology

These trials highlight an important effort to refine care for children with impaired growth.

Neurology research at this site includes studies in refractory partial onset epilepsy, where seizures remain difficult to control. The goal is to evaluate whether new or improved treatment approaches can reduce seizure frequency and offer better day-to-day stability for affected children.

• Drug-resistant focal onset seizures
• Levetiracetam research comparing treatment formulations
• Focus on seizure control and treatment effectiveness

These trials address a challenging pediatric neurologic condition with significant impact on quality of life.

Although fewer in number, the site’s broader pediatric research profile includes conditions linked to growth, kidney health, and systemic disease that can intersect with urogenital and developmental concerns. The emphasis remains on improving diagnosis, symptom control, and long-term disease management in young patients.

• Chronic kidney disease with related urinary complications
• Studies exploring better support for complex pediatric conditions
• Research aimed at improving overall clinical care

This area complements the site’s wider focus on chronic childhood diseases requiring specialized follow-up.

Immune-related research at the site includes pediatric conditions where inflammation plays a major role, especially juvenile idiopathic arthritis and inflammatory bowel disease. These trials are assessing whether targeted therapies can better control immune activity and improve daily functioning.

• Polyarticular-course juvenile idiopathic arthritis
• Filgotinib studies for safety, tolerability, and effectiveness
• Research focused on reducing inflammatory burden in children

Such studies help broaden options for pediatric patients with chronic immune-mediated disease.